Erlotinib Hydrochloride

Spécifications

183319-69-9Numéro CAS

620-491-0Numéro CE

N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochlorideNom IUPAC

C22H24ClN3O4Formule chimique

429.9 g/molMasse molaire

Erlotinib hydrochloride; 183319-69-9; erlotinib HCl; Tarceva; OSI-774; OSI 774; CP 358774; DA87705X9K; CP-358; CP-358,774-01; CP-358774; DTXSID10171412; CP-358774-01; NSC 718781; 4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride; NSC718781; 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride; CHEBI:53509; CP358774; CP-358,774; HCl, Erlotinib; 11C erlotinib; n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride; Hydrochloride, Erlotinib; RefChem:57242; OSI774; DTXCID7093903; CP358,774; 358774, CP; CP 358,774; 358,774, CP; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride; Erlotinib HCl (OSI-744); Erlotinib (Hydrochloride); MFCD07781272; C22H24ClN3O4; 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1); Tarceva (Erlotinib Hydrochloride); N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride; Erlotinib Hydrochloride (Tarceva); NSC-718781; 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; 6,7-Bis-(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; [6,7-BIS-(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)-AMINE HYDROCHLORIDE; CHEMBL1079742; SMR002529980; Erlotinib hydrochloride [USAN]; UNII-DA87705X9K; OSI-744; Erlotinib hydrochloride [USAN:INN]; Tarceva (OSI); Tarceva (TN); tarceva hydrochloride; Erlotinib hydrochloride?; Erlotinib(OSI-744); 183319-69-9 (HCl); Erlotinib hydrochloride salt; erlotinib, hydrochloride salt; SCHEMBL18563; MLS003899192; MLS004774139; orb1225863; orb1310677; orb3141191; SCHEMBL29460839; NSC 718781) HCl; EX-A064; 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl; GLXC-90093; HMS5087A15; Erlotinib hydrochloride (JAN/USAN); ERLOTINIB HYDROCHLORIDE [MI]; AC-400; EBC-00693; ERLOTINIB HYDROCHLORIDE [JAN]; HY-12008R; s1023; T0373L; Erlotinib (Hydrochloride) (Standard); AKOS015849087; Erlotinib hydrochloride [EP monograph]; CCG-269002; CS-0123; ERLOTINIB HYDROCHLORIDE [MART.]; FE10803; KS-1202; PB30965; SB16917; ERLOTINIB HYDROCHLORIDE [USP-RS]; ERLOTINIB HYDROCHLORIDE [WHO-DD]; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride.; Ro-50-8231; BE164421; BP-30224; HY-12008; SY007225; (CP358774; DB-011534; Erlotinib hydrochloride - Bio-X trade mark; E6846; ERLOTINIB HYDROCHLORIDE [ORANGE BOOK]; NS00076170; D04023; E-4007; EN300-123054; F036497; Q27124083; F0001-2385; Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781; N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl; [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride; N-(3-ETHENYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE; N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-quinazolin-4-amine hydrochloride; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine--hydrogen chloride (1/1); Hydrogen chloride - N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine (1:1:1)Synonymes